Post on 23-Feb-2016
description
How can we get to zero?The potential contribution of treatment
Peter Godfrey-Faussett and Bernhard SchwartlanderUNAIDS
WHO Satellite Symposium, Kuala Lumpur30 June 2013
1. Investment thinking and tools
2. New approaches and technologies
3. Impact on new HIV infections
4. Impact on AIDS-related deaths
Going to zero:
Towards an improved investment approach for an effective response to HIV/AIDS Lancet 2011Bernhard Schwartländer, John Stover, Timothy Hallett, Rifat Atun, Carlos Avila, Eleanor Gouws, Michael Bartos, Peter D Ghys, Marjorie Opuni, David Barr, Ramzi Alsallaq, Lori Bollinger, Marcelo de Freitas, Geoff rey Garnett, Charles Holmes, Ken Legins, Yogan Pillay, Anderson Eduardo Stanciole, Craig McClure, Gottfried Hirnschall, Marie Laga, Nancy Padian, on behalf of the Investment Framework Study Group*
UNDERSTAND SUSTAIN
1DESIGN
2DELIVER
3 4
Know your epidemic The What:Focus on the right things
The How:Doing things the right
way to go to scale
Sustain for impact
The tool – apply investment thinking to your response:4 simple steps
We are not starting from scratch! Virtually all countries have a national strategy
The tool is meant to support countries to identify - and act upon - opportunities for improvement
SYNERGIES WITH DEVELOPMENT SECTORSSocial protection; Education; Legal Reform; Gender equality; Poverty reduction; Gender-based violence; Health systems (incl. treatment of STIs, blood safety); Community systems; Employer practices.
CRITICAL ENABLERS
Social enablers• Political commitment &
advocacy• Laws, policies &
practices• Community
mobilization• Stigma reduction• Mass media
Programme enablers• Community-centered
design & delivery• Programme
communication• Management & incentives• Operations Research
TreatmentMale circumcision
Keeping people alive
BASIC PROGRAMME ACTIVITIES
Programs for keypopulations PMTCT
Condoms
OBJECTIVES
Stopping new infections
BehaviourChangeProgr.
New investment framework (2011) – focus & simplification
UNDERSTAND SUSTAIN
1DESIGN
2DELIVER
3 4
Where werethe last 1000
infections (Who and Where)?
Are there obvious mismatches?
Cutting cost (cost drivers!) and
efficiency in delivery
Shared responsibility,
innovative financing
The tool – apply investment thinking to your response:4 simple questions
Know your epidemic The What:Focus on the right things
The How:Doing things the right
way to go to scale
Sustain for impact
Spectrum and the Goals Modelwww.futuresinstitute.org
Coverage Targets for 2015 for the Investment Framework (IF) Generalized
EpidemicsConcentrated Epidemics
PMTCT 90% 90%Condoms (discordant couples) 60% 60%
Condoms (medium risk populations)
60% 20%
Condoms (high risk populations)
50% 50%
Sex work 60% 60%MSM 60% 60%IDU outreach 60% 60%IDU needle and syringe exchange
60% 60%
IDU drug substitution 0% 40%ART CD4<200 cells/µl 80% 80%ART CD4 200-250* cells/µl 70% 70%ART CD4 250-350 cells/µl 45% 45%ART CD4 350-500* cells/µl 5% 5%
• IF Investment Framework - as described above• IFE Enhanced IF - with addition of new WHO consolidated
ART guidelines• IFE + UT IFE with Universal Treatment
= Treatment regardless of CD4 count
• IFE + PrEP IFE with pre-exposure prophylaxis• IFE + Vaccine• IFE + UT + PrEP + Vaccine
Scenarios modeled
Scenario Definitions for New Prevention TechnologiesTechnology Population Groups Year of First
AvailabilityYear Target Coverage is Achieved
Target CoverageLow/High Scenarios
Effectiveness
Universal Treatment
All other HIV+ population withCD4 counts > 500 cells/µl
2014 2025 40% / 60% 96%(60%,80% for sensitivity analysis)
Pre-Exposure Prophylaxis
MSM 2013 2025 20% / 60% Before 2018: 44%After 2018: 70%/90%
Female sex workers 2018 2025 10% / 25%
Discordant couples 2020 2025 10% / 30% Adolescents in hyper-
endemics2018 2025 0% / 30%
Vaccine Adult population in generalized epidemics
2025 (high)2030 (low)
2032 (high)2035 (low)
40% / 70% 60% (low)80% (high)
High- risk population in concentrated epidemics
2025 (high)2030 (low)
2032 (high)2035 (low)
30% / 60%
20112014
20172020
20232026
20292032
20352038
20412044
20472050
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
4,000,000
4,500,000
BaseIFIF EnhancedIFE + TasP (high)IFE + PrEP (high)IFE + Vac (high)IFE + TsP + PrEP + Vac (high)
Going to Zero? The 2011 Investment Framework Combination prevention and treatment (current guidelines)
Number of new HIV infections
- Investment Framework
20112014
20172020
20232026
20292032
20352038
20412044
20472050
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
4,000,000
4,500,000
BaseIFIF EnhancedIFE + TasP (high)IFE + PrEP (high)IFE + Vac (high)IFE + TsP + PrEP + Vac (high)
Number of new HIV infections
Going to Zero? The 2011 Investment Framework Combination prevention and treatment (new guidelines)
- Investment Framework
20112014
20172020
20232026
20292032
20352038
20412044
20472050
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
4,000,000
4,500,000
BaseIFIF EnhancedIFE + TasP (high)IFE + PrEP (high)IFE + Vac (high)IFE + TsP + PrEP + Vac (high)
New technologies: critical in reaching zero new infections in both industrialized and LMI countries (e.g. vaccine)
Number of new HIV infections
- Investment Framework
• “All models are wrong – but some are useful”• “Investment thinking” clear that treatment is an
excellent investment and a cornerstone of the response
• New WHO guidelines (IFE) likely to substantially reduce the size of the future epidemic
• Treatment unlikely to be sufficient to achieve our goal of zero new infections
• Continued push for research into vaccines, cures, easier (eg long-acting) treatments and PrEP
Zero new HIV infections?
Resource needs (crude) – different investment scenarios
20112014
20172020
20232026
20292032
20352038
20412044
20472050
0
5
10
15
20
25
30
BaseIFIFE (new WHO guidelines)
Billion US $
- Investment Framework
- Investment Framework Enhanced (new WHO guidelines)
• From cost to investments (in health)• The Investment Framework is not just a case for investment in
HIV, it is about the “HOW” – how to maximise the returns• From “as much as possible” to: how can we invest for greatest
impact; and how we can get the resources to do so• Shared responsibility• Value for money is a core value of country programmes• The GF can be the most powerful instrument to incentivize
and support countries in investing strategically• It is possible to get on the path towards zero
Conclusions: A new paradigm in a replenishment dialogue
Going to Zero: Number of people on ART Different scenarios 2011 to 2050
Number of people on ART
2011 2012 2015 2020 2025 2030 2035 2040 2045 20500
5,000,000
10,000,000
15,000,000
20,000,000
25,000,000
Base
Investment Framework
IF Enhanced
IFE + TasP
IFE + TasP + PrEP + Vaccines
Going to Zero: Paths going to 15 by 50
Number of people on ART
2011 2012 2015 2020 2025 2030 2035 2040 2045 20500
5,000,000
10,000,000
15,000,000
20,000,000
25,000,000
Base
Investment Framework
IF Enhanced
IFE + TasP
IFE + TasP + PrEP + Vaccines15 million on ART
Going to Zero: Paths going to 15 by 50
Number of people on ART
2011 2012 2015 2020 2025 2030 2035 2040 2045 20500
5,000,000
10,000,000
15,000,000
20,000,000
25,000,000
Base
Investment Framework
IF Enhanced
IFE + TasP
IFE + TasP + PrEP + Vaccines15 million on ART
16 million deaths averted
• Millions of lives to be saved by scaling up treatment efficiently
• Immediate gains from prioritising those with advanced HIV
• Access and coverage for all people eligible• Longer term gains from treating earlier – infections
and co-morbidities averted• Impact on non-AIDS morbidity and mortality• Zero AIDS-related deaths
Going to zero.